- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07450885
"Turkse validatie- en betrouwbaarheidsstudie van het Brompton-ademhalingspatroonbeoordelingsinstrument bij astmapatiënten" (BPAT-Turkish)
Validiteit- en betrouwbaarheidsstudie van de Turkse versie van de Brompton Ademhalingspatroonbeoordelingsinstrument (BPAT) bij personen met astma
The purpose of this study is to evaluate the validity and reliability of the Turkish version of the Brompton Breathing Pattern Assessment Tool (BPAT) in individuals with asthma. This study aims to determine whether the BPAT is a valid and reliable tool for assessing breathing patterns in Turkish-speaking asthma patients. The research question being addressed is: "Is the Turkish version of the BPAT a valid and reliable tool for assessing breathing patterns in individuals with asthma?"
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
This study is designed to assess the validity and reliability of the Turkish version of the Brompton Breathing Pattern Assessment Tool (BPAT). BPAT is a well-established tool used to assess the breathing patterns of individuals with respiratory conditions. In this study, a group of asthma patients will be evaluated using the BPAT to determine its applicability and consistency in the Turkish-speaking population.
The reliability of the tool will be tested through repeated measurements, and its validity will be assessed by comparing BPAT results with other validated asthma assessment tools. The data will be analyzed to evaluate the internal consistency, test-retest reliability, and construct validity of the BPAT in a clinical asthma population.
The linguistic validation process will be conducted following the ISPOR Task Force guidelines, including forward translation, reconciliation, back-translation, and cognitive debriefing. The psychometric properties of the tool, including internal consistency, test-retest reliability, and construct validity, will be evaluated according to the COSMIN checklist standards.
Additionally, participant eligibility will be defined as individuals who are diagnosed with asthma and can understand and respond to questions in Turkish. The study will also explore any cultural adaptations necessary for the Turkish version of the BPAT to ensure its cultural relevance and accuracy in assessments.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
Istanbul
-
Istanbul, Istanbul, Turkije (Türkiye), 34844
- Süreyyapaşa Chest Diseases And Thoracic Surgery Training And Research Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
The participants for this study will be recruited from Health Sciences University, İstanbul Süreyyapaşa Chest Diseases and Chest Surgery Education and Research Hospital in Istanbul, Turkey. Participants will be selected based on the eligibility criteria outlined, including those diagnosed with severe persistent asthma as per the Global Initiative for Asthma (GINA) guidelines. Participants will be recruited from local clinics specializing in respiratory diseases and asthma management.
Beschrijving
Inclusion Criteria:
- Aged between 18 and 75 years
- Diagnosed with severe persistent asthma according to the Global Initiative for Asthma (GINA) criteria
- Native Turkish speaker
- Ability to read and write in Turkish
- Willingness to participate in the study
Exclusion Criteria:
- Having had a respiratory infection in the last 1 month
- Use of oral corticosteroids in the last 4 weeks
- Presence of malignancy, vasculitis, or pregnancy
- Body Mass Index (BMI) > 35 kg/m2
- Diagnosis of COPD or other primary respiratory diseases (excluding asthma)
- Any musculoskeletal, neurological, or cardiovascular condition that could interfere with breathing pattern assessment or impede potential respiratory physiotherapy applications
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: COHORT
- Tijdsperspectieven: PROSPECTIVE
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Asthma Patients
Individuals aged 18-75, diagnosed with severe persistent asthma according to GINA criteria, who are native Turkish speakers. |
A tool used to assess breathing patterns in asthma patients through clinical observation. A set of validated questionnaires and objective tests used to compare with BPAT results for construct validity |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Construct Validity of the Turkish Version of the Brompton Breathing Pattern Assessment Tool (BPAT)
Tijdsspanne: Baseline
|
The study aims to evaluate the construct validity of the Turkish version of the BPAT in assessing breathing patterns among Turkish-speaking asthma patients. Validity will be determined by calculating correlation coefficients (e.g., Spearman's or Pearson's r) between the total BPAT scores, objective physiological measures (spirometry results such as FEV1 and FVC), and the scores of established reference clinical tools (Nijmegen Questionnaire, Dyspnea-12, Asthma Control Test (ACT), and Asthma Quality of Life Questionnaire (Mini-AQLQ). |
Baseline
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Test-Retest Reliability of the Turkish Version of BPAT
Tijdsspanne: 7 to 14 days
|
This outcome will assess the test-retest reliability of the Turkish version of BPAT by measuring the consistency of the tool in repeated assessments. The BPAT will be administered twice to the same participants. Reliability will be evaluated by calculating the Intraclass Correlation Coefficient (ICC). |
7 to 14 days
|
|
Inter-Rater Reliability of the Turkish Version of BPAT
Tijdsspanne: Baseline
|
This outcome will assess the inter-rater reliability of the Turkish version of BPAT. Two independent physiotherapists will evaluate the breathing pattern of the same asthma patient. The raters will be blinded to each other's scores to determine the consistency of the tool's application between different users. Reliability will be evaluated by calculating the Intraclass Correlation Coefficient (ICC) or Cohen's Kappa. |
Baseline
|
|
Comparison of BPAT Results with Other Asthma Assessment Tools
Tijdsspanne: Baseline
|
Description: This outcome will compare the BPAT results with other validated asthma assessment tools, such as Nijmegen Questionnaire, Dyspnea-12 Questionnaire , spirometry, ACT (Asthma Control Test), and Mini AQLQ (Asthma Quality of Life Questionnaire), to determine the congruence between different assessment methods. |
Baseline
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Zuhal Kunduracılar, Prof., Istanbul Gelisim University
- Studie stoel: Fatma M. Tepetam, Prof., Saglik Bilimleri Universitesi
- Studie stoel: Şeyma Ozden, Dr., Saglik Bilimleri Universitesi
- Hoofdonderzoeker: Dilek Unsal, PT PhD(c), Saglik Bilimleri Universitesi
- Studie stoel: Nisanur Tutus, PT Phd (c), Saglik Bilimleri Universitesi
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 25/428
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Individual participant data will not be publicly shared in order to protect patient confidentiality and comply with the local ethics committee regulations. However, completely anonymized data may be made available upon reasonable academic request to the Principal Investigator following the publication of the study results.
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .